Evercore Cuts Procter & Gamble Target to $162, Signaling 9.38% Upside
Evercore ISI lowered its price target for Procter & Gamble to $162, suggesting 9.38% upside from a $148.11 share price and downgrading the rating to hold. The company posted 3.0% organic Q3 sales growth—2.0% volume, 1.0% pricing—across all categories and returned $3.2 billion in dividends and buybacks.
1. Analyst Revises Price Target
Evercore ISI lowered its price target for Procter & Gamble from $170 to $162 and downgraded the stock to hold, implying a 9.38% upside from the $148.11 share price at the time of the revision.
2. Broad-Based Q3 Organic Growth
Procter & Gamble reported 3.00% organic sales growth in its third quarter, driven by a 2.00% increase in volume and a 1.00% gain from higher pricing, with growth spanning all ten product categories and seven geographic regions, including a 4.00% rise in North America and a 3.00% increase in Greater China.
3. $3.2 Billion Returned to Shareholders
The company returned $3.20 billion to investors in the quarter, composed of $2.50 billion in dividends and over $600 million in share repurchases, supporting shareholder value and reducing outstanding shares.